ValiRx (LON:VAL) Announces Earnings Results

ValiRx (LON:VAL) posted its quarterly earnings data on Wednesday. The company reported GBX (32.50) (($0.40)) earnings per share for the quarter, Digital Look Earnings reports.

VAL traded up GBX 0.25 ($0.00) during trading on Friday, reaching GBX 8 ($0.10). The stock had a trading volume of 281,067 shares, compared to its average volume of 3,820,000. The business has a 50-day moving average of GBX 7.80 and a 200-day moving average of GBX 2.96. ValiRx has a one year low of GBX 0.03 ($0.00) and a one year high of GBX 22.90 ($0.28). The company has a debt-to-equity ratio of 6.37, a quick ratio of 0.95 and a current ratio of 0.95. The stock has a market cap of $2.89 million and a PE ratio of -0.13.

ValiRx Company Profile

ValiRx plc, a biotechnology oncology focused company, engages in developing novel treatments for cancer and associated biomarkers in the United Kingdom. Its proprietary GeneICE technology enables the selective silencing of specific genes by targeted histone deacetylation leading to chromatin condensation.

See Also: Buy-Side Analysts

Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.